Ainapure S S, Desai A, Korde K
Department of Pharmacology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Mumbai.
J Indian Med Assoc. 2001 Feb;99(2):111, 114.
A total of 768 patients were recruited by 81 physicians and paediatricians all over the country in this National Study Group of 'Ascoril + Expectorant'. The results of this first large scale study of a cough formula indicates that 'Ascoril + Expectorant' is effective in controlling cough, breathlessness and decreasing the volume of sputum. No serious adverse events were noted. Ascoril was well accepted by the patients and its efficacy was rated very high by the physician. The National Study Group concludes that 'Ascoril + Expectorant' is highly effective in the management of cough associated with lower respiratory tract infection and COPDs.
在“阿斯可立+祛痰剂”全国研究组中，来自全国各地的81名内科医生和儿科医生共招募了768名患者。这项关于止咳配方的首次大规模研究结果表明，“阿斯可立+祛痰剂”在控制咳嗽、呼吸急促以及减少痰液量方面有效。未观察到严重不良事件。患者对阿斯可立接受度良好，医生对其疗效评价很高。全国研究组得出结论，“阿斯可立+祛痰剂”在治疗下呼吸道感染和慢性阻塞性肺疾病相关咳嗽方面非常有效。
